Patients with Structural Heart Disease, Syncope of Unknown Origin and Suspected Ventricular Tachycardia: ICD Implantation or “Wait and See” Strategy?

  • C. Menozzi
  • N. Bottoni
  • M. Brignole
Conference paper


From a practical point of view it is useful to consider two different major determinants of outcome, namely the inducibility or not of ventricular tachyarrhythmias by means of premature ventricular stimulation and the presence or absence of a markedly depressed cardiac function. These two situations are variously combined.


Ventricular Tachycardia Ventricular Arrhythmia Structural Heart Disease Ventricular Tachyarrhythmia Advanced Heart Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bigger JT Jr, Reiffei JA, Livelli FD, Wang PJ (1986) Sensitivity, specificity, and reprodu-cibility of programmed ventricular stimulation. Circulation 73 [Suppl II]:73–78CrossRefGoogle Scholar
  2. 2.
    Wellens HJJ, Brugada P, Stevenson WG (1986) Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 72:1–7CrossRefGoogle Scholar
  3. 3.
    Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW (1999) Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. Am Heart J 137:878–886PubMedCrossRefGoogle Scholar
  4. 4.
    Englund A, Bergfeldt L, Rehnqvist N, Åström H, Rosenqvist M (1995) Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol 26:1508–1515PubMedCrossRefGoogle Scholar
  5. 5.
    Alings M, Wilde A (1999) “Brugada” syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 99:666–673Google Scholar
  6. 6.
    Brugada J, Brugada P, Brugada R (1999) The syndrome of right bundle branch block ST segment elevation in VI to V3 and sudden death—the Brugada syndrome. Europace 1:156–166PubMedCrossRefGoogle Scholar
  7. 7.
    Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ Jr, Freeman CS, Garan H (1990) Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 15:267–273PubMedCrossRefGoogle Scholar
  8. 8.
    Bergfeldt L (1999) CABG and ICD for all patients with hemodynamically significant ventricular arrhythmia and significant coronary artery disease? Do we know enough to decide—or to design a randomized trial? Pacing Clin Electrophysiol 22:1129–1131PubMedCrossRefGoogle Scholar
  9. 9.
    Link M, Kim KM, Homoud M et al (1999) Long-term outcome of patients with syncope associated with coronary artery disease and nondiagnostic electrophysiologic evaluation. Am J Cardiol 83:1334–1337PubMedCrossRefGoogle Scholar
  10. 10.
    Middlekauff H, Stevenson W, Stevenson L, Saxon L (1993) Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 21:110–116PubMedCrossRefGoogle Scholar
  11. 11.
    Knight B, Goyal R, Pelosi F et al (1999) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 33:1964–1970PubMedCrossRefGoogle Scholar
  12. 12.
    Brilakis E, Shen W, Hammill S et al (2001) Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol 24:1623–1630PubMedCrossRefGoogle Scholar
  13. 13.
    Menozzi C, Brignole M, Garcia-Civera R et al (2002) Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 105:2741–2745PubMedCrossRefGoogle Scholar
  14. 14.
    Link MS, Costeas XF, Griffith JL et al (1997) High incidence of appropriate implanta-ble cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular tachycardia. J Am Coll Cardiol 29:370–375PubMedCrossRefGoogle Scholar
  15. 15.
    Militianu A, Salacata A, Seibert K et al (1997) Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 8:1087–1097PubMedCrossRefGoogle Scholar
  16. 16.
    Mittal S, Iwai S, Stein K, Markowitz S, Slotwiner D, Lerman B (1999) Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 34:1082–1089PubMedCrossRefGoogle Scholar
  17. 17.
    Andrews N, Fogel R, Pelargonio G, Evans J, Prystowsky E (1999) Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 34:2023–2030PubMedCrossRefGoogle Scholar
  18. 18.
    Pires L, May L, Ravi S, Parry T, LaI V, Nino C (2000) Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillator. Am J Cardiol 85:725–728PubMedCrossRefGoogle Scholar
  19. 19.
    Fonarow G, Feliciano Z, Boyle N et al (2000) Improved survival in patients with noni-schemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol 85:981–985PubMedCrossRefGoogle Scholar
  20. 20.
    Doherty J, Pembrook-Rogers D, Grogan W et al (1985) Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol 55:703–708PubMedCrossRefGoogle Scholar
  21. 21.
    Proclemer A, Gianfagna P, Fontanelli P et al (1987) Value of electrophysiologic testing in long term follow-up of patients with syncope of unknown cause. G Ital Cardiol 17:402–407PubMedGoogle Scholar
  22. 22.
    Kushner J, Hou W, Kadish A et al (2001) Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study. J Am Coll Cardiol 14:391–396CrossRefGoogle Scholar
  23. 23.
    Krahn A, Klein G, Yee R et al (2001) Randomized assessment of syncope trial. Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104:46–51Google Scholar
  24. 24.
    Brignole M, Alboni P, Benditt D et al, for the Task Force on Syncope of the European Society of Cardiology (2001) Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1256–1306PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • C. Menozzi
    • 1
  • N. Bottoni
    • 1
  • M. Brignole
    • 2
  1. 1.Department of Interventional CardiologyOspedale S. Maria NuovaReggio EmiliaItaly
  2. 2.Department of Cardiology and Arrhythmologic CentreOspedali RiunitiLavagnaItaly

Personalised recommendations